Zealthy and infertility in India

The average infertility rate in Indian married couples is around 10-15% Of which only 45% visit a doctor for help and a mere 1% receive infertility treatments. Zealthy is deciding to change how women deal with reproductive health.

Infertility is a problem that globally affects around 15% of all reproductive-age couples. The World Health Organisation (WHO) says that the prevalence of primary infertility in India is between 3.9 to 16.8%. A research conducted by Inito, a Bengaluru-based firm, claims that the average infertility rate in Indian married couples is around 10-15% Within such couples, only 45% visit a doctor for help and a mere 1% receive infertility treatments. A majority of couples rely on homemade remedies and other options that are not clinically proven. 

A huge reason is that there is a lack of awareness in women regarding their reproductive health. To bridge this gap, Akhil Gupta and Rishi Malhotra founded Zealthy in 2018. Zealthy is a health company dedicated to helping women make informed decisions regarding their reproductive health, in areas like fertility and pregnancy. Their offerings are FSSAI and ISO approved and clinically proven. 

The Banglore-based startup offers services and support even for period-related problems like menopause, PCOS (Polycystic Ovary Syndrome) and other conditions. They also provide treatments like IVF, IUI, Surrogacy, Laparoscopy and Hysteroscopy. 

They have partnered with 150+ healthcare players including Apollo Cradle, Milann, Morpheus, Motherhood, and other maternity homes. Since its inception, they have helped over 10,000 mothers with pregnancy. They are currently present in 50+ cities and aim to establish themselves in 150 cities. Zealthy’s parent company, Zuddy Healthtech has raised an undisclosed amount from KYT Ventures, First Cheque, AngelList and other angel investors like MPL’s Shubham Malhotra and former SoftBank director Pavan Ongole. 

The company was generating 5x revenue in August 2020 and they plan to reach Rs 1 crore per month in the coming days and enter tier 2 and tier 3 cities. They also want to expand from English and Hindi into regional languages like Bengali, Tamil, Telugu and Malayalam.

Will Zealthy be able to show growth despite severe competition in the women health segment from Healofy and BabyChakra and even in the women-based e-commerce space with competitors like Nua, PeeSafe, Azah and others?

Tags : #Zealthy #AkhilGupta #RishiMalhotra #womenreproductivehealth #infertility #pregnancy #infertilitytreatments #MediSpeak #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026
Metropolis Healthcare reports strong Q1FY27 performance, with revenue up 17% to ₹450 crore and EBITDA up 27% YoYAugust 04, 2026
India's Silent Liver Health Crisis: New Data Points to Urgent Need for Screening and PreventionAugust 04, 2026
Eureka Forbes Launches 'Ghar Ka New Favourite' Campaign showcasing Forbes SmartClean Robotic Vacuum Cleaner with Shraddha KapoorAugust 04, 2026
Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026
Common Medical Terms Explained: A Plain-Language Guide for Indian Patients and Healthcare SeekersAugust 03, 2026
Why Radiology Is the Backbone of Modern Medical Diagnosis and TreatmentAugust 03, 2026
Managing Urban Stress: Science-Backed Strategies for Mental Resilience in 2026 August 01, 2026
Managing Chronic Inflammation: The Role of Anti-Inflammatory Indian SuperfoodsAugust 01, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 01, 2026
Early Markers of Glaucoma: Structural vs. Functional Ophthalmic Diagnostic ProtocolsAugust 01, 2026
Managing Complex Diabetic Foot Ulcers: Multidisciplinary Wound Care, Offloading, and RevascularizationAugust 01, 2026
The Future of Preventive Medicine: How India Is Moving From Cure to PreventionAugust 01, 2026